Search Results - "Cavé, Helene"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia by Olivier‐Gougenheim, Laura, Arfeuille, Chloe, Suciu, Stefan, Sirvent, Nicolas, Plat, Geneviève, Ferster, Alina, de Moerloose, Barbara, Domenech, Carine, Uyttebroeck, Anne, Rohrlich, Pierre‐Simon, Cavé, Helene, Bertrand, Yves

    Published in Hematological oncology (01-12-2020)
    “…Over the years, the prognosis of adolescents treated for acute lymphoblastic leukemia (ALL) has improved. However, this age group still represents a challenge…”
    Get full text
    Journal Article
  6. 6

    IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? by Stanulla, Martin, Cavé, Hélène, Moorman, Anthony V.

    Published in Blood (23-01-2020)
    “…Improved personalized adjustment of primary therapy to the perceived risk of relapse by using new prognostic markers for treatment stratification may be…”
    Get full text
    Journal Article
  7. 7

    ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation by Gelb, Bruce D, Cavé, Hélène, Dillon, Mitchell W, Gripp, Karen W, Lee, Jennifer A, Mason-Suares, Heather, Rauen, Katherine A, Williams, Bradley, Zenker, Martin, Vincent, Lisa M

    Published in Genetics in medicine (01-11-2018)
    “…Purpose Standardized and accurate variant assessment is essential for effective medical care. To that end, Clinical Genome (ClinGen) Resource clinical domain…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Neonatal diabetes mellitus: a disease linked to multiple mechanisms by Polak, Michel, Cavé, Hélène

    Published in Orphanet journal of rare diseases (09-03-2007)
    “…Transient (TNDM) and Permanent (PNDM) Neonatal Diabetes Mellitus are rare conditions occurring in 1:300,000-400,000 live births. TNDM infants develop diabetes…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects by Solman, Maja, Blokzijl-Franke, Sasja, Piques, Florian, Yan, Chuan, Yang, Qiqi, Strullu, Marion, Kamel, Sarah M, Ak, Pakize, Bakkers, Jeroen, Langenau, David M, Cavé, Hélène, den Hertog, Jeroen

    Published in eLife (10-05-2022)
    “…Gain-of-function mutations in the protein-tyrosine phosphatase SHP2 are the most frequently occurring mutations in sporadic juvenile myelomonocytic leukemia…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis by Vial, Yoann, Nardelli, Jeannette, Bonnard, Adeline A, Rousselot, Justine, Souyri, Michèle, Gressens, Pierre, Cavé, Hélène, Drunat, Séverine

    Published in EMBO reports (14-05-2024)
    “…Microcephaly is a common feature in inherited bone marrow failure syndromes, prompting investigations into shared pathways between neurogenesis and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Activating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus by Babenko, Andrey P, Polak, Michel, Cavé, Hélène, Busiah, Kanetee, Czernichow, Paul, Scharfmann, Raphael, Bryan, Joseph, Aguilar-Bryan, Lydia, Vaxillaire, Martine, Froguel, Philippe

    Published in The New England journal of medicine (03-08-2006)
    “…In this study, mutations in the gene encoding the sulfonylurea receptor, a component of the beta-cell ATP-sensitive potassium channel, are described in infants…”
    Get full text
    Journal Article